TreeWAS – Variant ID: rs11118346

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Showing all nodes without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
K42.9 Umbilical hernia without obstruction or gangrene	0.000	0.000	1.000
K42 Umbilical hernia	0.000	0.000	1.000
K40-K46 Hernia	0.000	0.000	1.000
K40 Inguinal hernia	0.000	0.000	1.000
K40.2 Bilateral inguinal hernia, without obstruction or gangrene	0.000	0.002	0.998
K43 Ventral hernia	0.000	0.004	0.996
K43.9 Ventral hernia without obstruction or gangrene	0.000	0.005	0.995
K40.9 Unilateral or unspecified inguinal hernia, without obstruction or gangrene	0.000	0.021	0.979
K42.0 Umbilical hernia with obstruction, without gangrene	0.000	0.024	0.976
K41 Femoral hernia	0.000	0.059	0.941
K41.9 Unilateral or unspecified femoral hernia, without obstruction or gangrene	0.000	0.094	0.906
K46 Unspecified abdominal hernia	0.000	0.155	0.845
K45 Other abdominal hernia	0.000	0.166	0.834
K40.4 Unilateral or unspecified inguinal hernia, with gangrene	0.000	0.255	0.745
K46.9 Unspecified abdominal hernia without obstruction or gangrene	0.000	0.271	0.729
K42.1 Umbilical hernia with gangrene	0.000	0.283	0.717
K40.1 Bilateral inguinal hernia, with gangrene	0.000	0.283	0.717
K43.7 Other and unspecified ventral hernia with gangrene	0.000	0.286	0.714
K43.6 Other and unspecified ventral hernia with obstruction, without gangrene	0.000	0.286	0.714
K43.5 Parastomal hernia without obstruction or gangrene	0.000	0.286	0.714
K43.4 Parastomal hernia with gangrene	0.000	0.286	0.714
K43.3 Parastomal hernia with obstruction, without gangrene	0.000	0.286	0.714
K43.2 Incisional hernia without obstruction or gangrene	0.000	0.286	0.714
K43.1 Ventral hernia with gangrene	0.000	0.286	0.714
K45.0 Other specified abdominal hernia with obstruction, without gangrene	0.000	0.286	0.714
K41.4 Unilateral or unspecified femoral hernia, with gangrene	0.000	0.325	0.675
K41.2 Bilateral femoral hernia, without obstruction or gangrene	0.000	0.325	0.675
K41.1 Bilateral femoral hernia, with gangrene	0.000	0.325	0.675
K41.0 Bilateral femoral hernia, with obstruction, without gangrene	0.000	0.325	0.675
K41.3 Unilateral or unspecified femoral hernia, with obstruction, without gangrene	0.000	0.372	0.628
K46.0 Unspecified abdominal hernia with obstruction, without gangrene	0.000	0.385	0.615
K46.1 Unspecified abdominal hernia with gangrene	0.000	0.394	0.606
K45.8 Other specified abdominal hernia without obstruction or gangrene	0.000	0.399	0.601
K40.3 Unilateral or unspecified inguinal hernia, with obstruction, without gangrene	0.000	0.401	0.599
K45.1 Other specified abdominal hernia with gangrene	0.000	0.402	0.598
K40.0 Bilateral inguinal hernia, with obstruction, without gangrene	0.000	0.433	0.567
K43.0 Ventral hernia with obstruction, without gangrene	0.000	0.590	0.409
K44 Diaphragmatic hernia	0.000	0.619	0.381
K44.0 Diaphragmatic hernia with obstruction, without gangrene	0.000	0.722	0.278
K44.1 Diaphragmatic hernia with gangrene	0.000	0.751	0.248
T46 Poisoning by agents primarily affecting the cardiovascular system	0.224	0.776	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.215	0.785	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.210	0.790	0.000
T46.1 Calcium-channel blockers	0.209	0.791	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.187	0.813	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.186	0.814	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.175	0.825	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.175	0.825	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.173	0.827	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.170	0.830	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.161	0.838	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.160	0.839	0.000
T46.7 Peripheral vasodilators	0.160	0.839	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.160	0.839	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.160	0.839	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.160	0.840	0.000
T39.1 4-Aminophenol derivatives	0.154	0.846	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.153	0.847	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.147	0.853	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.145	0.855	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.142	0.857	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.142	0.858	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.137	0.863	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.136	0.864	0.000
T45.0 Antiallergic and antiemetic drugs	0.136	0.864	0.000
T36 Poisoning by systemic antibiotics	0.135	0.865	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.134	0.866	0.000
H33.0 Retinal detachment with retinal break	0.132	0.868	0.000
T40.6 Other and unspecified narcotics	0.130	0.870	0.000
T42.1 Iminostilbenes	0.129	0.870	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.129	0.870	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.126	0.874	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.125	0.874	0.000
T42.3 Barbiturates	0.125	0.874	0.000
T42.2 Succinimides and oxazolidinediones	0.125	0.874	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.124	0.876	0.000
T45.2 Vitamins, not elsewhere classified	0.124	0.876	0.000
H33 Retinal detachments and breaks	0.121	0.879	0.000
H33.2 Serous retinal detachment	0.116	0.884	0.000
T39.4 Antirheumatics, not elsewhere classified	0.116	0.884	0.000
T39.2 Pyrazolone derivatives	0.116	0.884	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.114	0.885	0.000
H33.3 Retinal breaks without detachment	0.115	0.885	0.000
T40.3 Methadone	0.112	0.888	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.110	0.889	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.110	0.890	0.000
T45.8 Other primarily systemic and haematological agents	0.110	0.890	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.110	0.890	0.000
T45.6 Fibrinolysis-affecting drugs	0.110	0.890	0.000
T45.4 Iron and its compounds	0.110	0.890	0.000
T45.3 Enzymes, not elsewhere classified	0.110	0.890	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.110	0.890	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.106	0.894	0.000
T40.8 Lysergide [LSD]	0.106	0.894	0.000
T40.7 Cannabis (derivatives)	0.106	0.894	0.000
T40.1 Heroin	0.106	0.894	0.000
T40.0 Opium	0.106	0.894	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.105	0.894	0.000
T40.5 Cocaine	0.104	0.895	0.000
T49.9 Topical agent, unspecified	0.104	0.896	0.000
T49.8 Other topical agents	0.104	0.896	0.000
T49.7 Dental drugs, topically applied	0.104	0.896	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.104	0.896	0.000
T49.5 Ophthalmological drugs and preparations	0.104	0.896	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.104	0.896	0.000
T49.3 Emollients, demulcents and protectants	0.104	0.896	0.000
T49.2 Local astringents and local detergents	0.104	0.896	0.000
T49.1 Antipruritics	0.104	0.896	0.000
T48.5 Anti-common-cold drugs	0.104	0.896	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.102	0.898	0.000
T37.5 Antiviral drugs	0.102	0.898	0.000
T37.4 Anthelminthics	0.102	0.898	0.000
T37.3 Other antiprotozoal drugs	0.102	0.898	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.102	0.898	0.000
T37.1 Antimycobacterial drugs	0.102	0.898	0.000
T37.0 Sulphonamides	0.102	0.898	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.101	0.899	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.101	0.899	0.000
T36.3 Macrolides	0.099	0.900	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.099	0.901	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.098	0.901	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.098	0.901	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.098	0.901	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.098	0.901	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.098	0.901	0.000
T44.0 Anticholinesterase agents	0.098	0.901	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.098	0.902	0.000
T48.4 Expectorants	0.098	0.902	0.000
T48.3 Antitussives	0.098	0.902	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.098	0.902	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.098	0.902	0.000
T48.0 Oxytocic drugs	0.098	0.902	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.098	0.902	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.097	0.902	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.097	0.902	0.000
T36.9 Systemic antibiotic, unspecified	0.097	0.903	0.000
T36.8 Other systemic antibiotics	0.097	0.903	0.000
T36.7 Antifungal antibiotics, systemically used	0.097	0.903	0.000
T36.6 Rifamycins	0.097	0.903	0.000
T36.5 Aminoglycosides	0.097	0.903	0.000
T36.4 Tetracyclines	0.097	0.903	0.000
T36.2 Chloramphenicol group	0.097	0.903	0.000
T41.5 Therapeutic gases	0.096	0.903	0.000
T41.4 Anaesthetic, unspecified	0.096	0.903	0.000
T41.3 Local anaesthetics	0.096	0.903	0.000
T41.2 Other and unspecified general anaesthetics	0.096	0.903	0.000
T41.1 Intravenous anaesthetics	0.096	0.903	0.000
T41.0 Inhaled anaesthetics	0.096	0.903	0.000
I21.1 Acute transmural myocardial infarction of inferior wall	0.096	0.904	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.094	0.905	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.093	0.907	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.093	0.907	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.093	0.907	0.000
T47.7 Emetics	0.093	0.907	0.000
T47.5 Digestants	0.093	0.907	0.000
T47.3 Saline and osmotic laxatives	0.093	0.907	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.093	0.907	0.000
T47.0 Histamine H(2)-receptor antagonists	0.092	0.908	0.000
T47.2 Stimulant laxatives	0.092	0.908	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.091	0.909	0.000
T47.6 Antidiarrhoeal drugs	0.091	0.909	0.000
T38.9 Other and unspecified hormone antagonists	0.090	0.909	0.000
T38.7 Androgens and anabolic congeners	0.090	0.909	0.000
T38.5 Other oestrogens and progestogens	0.090	0.909	0.000
T38.4 Oral contraceptives	0.090	0.909	0.000
T38.2 Antithyroid drugs	0.090	0.909	0.000
T38.0 Glucocorticoids and synthetic analogues	0.090	0.909	0.000
T40.4 Other synthetic narcotics	0.090	0.910	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.089	0.911	0.000
T40.2 Other opioids	0.089	0.911	0.000
H33.4 Traction detachment of retina	0.089	0.911	0.000
T42.0 Hydantoin derivatives	0.087	0.913	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.085	0.915	0.000
T47.4 Other laxatives	0.083	0.916	0.000
T36.0 Penicillins	0.083	0.917	0.000
T45.5 Anticoagulants	0.082	0.918	0.000
T38.1 Thyroid hormones and substitutes	0.080	0.919	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.080	0.919	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.078	0.922	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.075	0.925	0.000
T50.8 Diagnostic agents	0.073	0.927	0.000
H30-H36 Disorders of choroid and retina	0.072	0.928	0.000
H36.0 Diabetic retinopathy	0.071	0.929	0.000
H36 Retinal disorders in diseases classified elsewhere	0.071	0.929	0.000
T50.7 Analeptics and opioid receptor antagonists	0.070	0.929	0.000
T50.5 Appetite depressants	0.070	0.929	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.070	0.929	0.000
T50.1 Loop [high-ceiling] diuretics	0.070	0.929	0.000
T50.0 Mineralocorticoids and their antagonists	0.070	0.929	0.000
T50.4 Drugs affecting uric acid metabolism	0.067	0.933	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.067	0.933	0.000
H31 Other disorders of choroid	0.064	0.936	0.000
T43.9 Psychotropic drug, unspecified	0.064	0.936	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.064	0.936	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.064	0.936	0.000
T39.0 Salicylates	0.064	0.936	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.058	0.942	0.000
T43.2 Other and unspecified antidepressants	0.058	0.942	0.000
H33.1 Retinoschisis and retinal cysts	0.056	0.944	0.000
H31.8 Other specified disorders of choroid	0.055	0.944	0.000
T43.6 Psychostimulants with abuse potential	0.053	0.947	0.000
H32 Chorioretinal disorders in diseases classified elsewhere	0.052	0.948	0.000
H36.8 Other retinal disorders in diseases classified elsewhere	0.051	0.949	0.000
H31.9 Disorder of choroid, unspecified	0.051	0.949	0.000
H31.0 Chorioretinal scars	0.050	0.950	0.000
H31.3 Choroidal haemorrhage and rupture	0.048	0.952	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.047	0.953	0.000
H31.4 Choroidal detachment	0.046	0.954	0.000
H31.2 Hereditary choroidal dystrophy	0.046	0.954	0.000
H30 Chorioretinal inflammation	0.046	0.954	0.000
H31.1 Choroidal degeneration	0.044	0.956	0.000
H32.8 Other chorioretinal disorders in diseases classified elsewhere	0.037	0.963	0.000
H32.0 Chorioretinal inflammation in infectious and parasitic diseases classified elsewhere	0.037	0.963	0.000
H33.5 Other retinal detachments	0.034	0.965	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.035	0.965	0.000
H30.8 Other chorioretinal inflammations	0.033	0.967	0.000
H30.2 Posterior cyclitis	0.033	0.967	0.000
H30.1 Disseminated chorioretinal inflammation	0.033	0.967	0.000
H30.0 Focal chorioretinal inflammation	0.033	0.967	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.030	0.970	0.000
H30.9 Chorioretinal inflammation, unspecified	0.027	0.973	0.000
M16.1 Other primary coxarthrosis	0.000	0.976	0.024
T42.4 Benzodiazepines	0.023	0.977	0.000
H34 Retinal vascular occlusions	0.023	0.977	0.000
H34.0 Transient retinal artery occlusion	0.016	0.983	0.000
H34.9 Retinal vascular occlusion, unspecified	0.016	0.984	0.000
Z92.3 Personal history of irradiation	0.016	0.984	0.000
H34.1 Central retinal artery occlusion	0.015	0.985	0.000
Y84.2 Radiological procedure and radiotherapy	0.015	0.985	0.000
H34.2 Other retinal artery occlusions	0.013	0.987	0.000
Z95.5 Presence of coronary angioplasty implant and graft	0.010	0.990	0.000
M16 Coxarthrosis [arthrosis of hip]	0.000	0.991	0.009
Z92.6 Personal history of chemotherapy for neoplastic disease	0.009	0.991	0.000
O34.2 Maternal care due to uterine scar from previous surgery	0.008	0.992	0.000
M16.9 Coxarthrosis, unspecified	0.000	0.992	0.008
Z50.2 Alcohol rehabilitation	0.008	0.992	0.000
C67 Malignant neoplasm of bladder	0.008	0.992	0.000
R44.1 Visual hallucinations	0.000	0.993	0.007
C67.5 Bladder neck	0.007	0.993	0.000
R44.8 Other and unspecified symptoms and signs involving general sensations and perceptions	0.000	0.993	0.007
M16.3 Other dysplastic coxarthrosis	0.000	0.993	0.007
R44 Other symptoms and signs involving general sensations and perceptions	0.000	0.993	0.007
C67.3 Anterior wall of bladder	0.007	0.993	0.000
C67.1 Dome of bladder	0.007	0.993	0.000
M16.7 Other secondary coxarthrosis	0.000	0.993	0.007
Z01.9 Special examination, unspecified	0.007	0.993	0.000
M16.4 Posttraumatic coxarthrosis, bilateral	0.000	0.993	0.007
C67.0 Trigone of bladder	0.006	0.994	0.000
M16.6 Other secondary coxarthrosis, bilateral	0.000	0.994	0.006
R44.0 Auditory hallucinations	0.000	0.994	0.006
I87.8 Other specified disorders of veins	0.000	0.994	0.006
M16.0 Primary coxarthrosis, bilateral	0.000	0.994	0.006
C67.6 Ureteric orifice	0.006	0.994	0.000
C67.9 Bladder, unspecified	0.006	0.994	0.000
C67.4 Posterior wall of bladder	0.006	0.994	0.000
R44.3 Hallucinations, unspecified	0.000	0.994	0.006
Z45.0 Adjustment and management of cardiac pacemaker	0.000	0.994	0.006
C67.7 Urachus	0.006	0.994	0.000
R44.2 Other hallucinations	0.000	0.994	0.006
C67.2 Lateral wall of bladder	0.006	0.994	0.000
C67.8 Overlapping lesion of bladder	0.005	0.994	0.000
M16.2 Coxarthrosis resulting from dysplasia, bilateral	0.000	0.995	0.005
M16.5 Other posttraumatic coxarthrosis	0.000	0.995	0.005
M17.0 Primary gonarthrosis, bilateral	0.005	0.995	0.000
H34.8 Other retinal vascular occlusions	0.005	0.995	0.000
Z29.0 Isolation	0.005	0.995	0.000
B02.9 Zoster without complication	0.005	0.995	0.000
K14.9 Disease of tongue, unspecified	0.005	0.995	0.000
B98.0 Helicobacter pylori [H.pylori] as the cause of diseases classified to other chapters	0.000	0.995	0.005
M47.90 Spondylosis, unspecified (Multiple sites in spine)	0.000	0.996	0.004
C54.1 Endometrium	0.000	0.996	0.004
S89.9 Unspecified injury of lower leg	0.004	0.996	0.000
Z01.7 Laboratory examination	0.004	0.996	0.000
Z92 Personal history of medical treatment	0.004	0.996	0.000
Z01.5 Diagnostic skin and sensitisation tests	0.004	0.996	0.000
Z01 Other special examinations and investigations of persons without complaint or reported diagnosis	0.004	0.996	0.000
Z92.5 Personal history of rehabilitation measures	0.004	0.996	0.000
M62.85 Other specified disorders of muscle (Pelvic region and thigh)	0.004	0.996	0.000
H61.1 Non-infective disorders of pinna	0.004	0.996	0.000
B97.8 Other viral agents as the cause of diseases classified to other chapters	0.004	0.996	0.000
Z48.8 Other specified surgical follow-up care	0.004	0.996	0.000
K86.3 Pseudocyst of pancreas	0.004	0.996	0.000
Z01.6 Radiological examination, not elsewhere classified	0.004	0.996	0.000
O34 Maternal care for known or suspected abnormality of pelvic organs	0.004	0.996	0.000
I87 Other disorders of veins	0.000	0.996	0.004
Z01.3 Examination of blood pressure	0.003	0.996	0.000
H61.9 Disorder of external ear, unspecified	0.003	0.997	0.000
I87.2 Venous insufficiency (chronic) (peripheral)	0.000	0.997	0.003
H61.0 Perichondritis of external ear	0.003	0.997	0.000
S82.50 Fracture of medial malleolus (closed)	0.000	0.997	0.003
J61 Pneumoconiosis due to asbestos and other mineral fibres	0.003	0.997	0.000
Z92.9 Personal history of medical treatment, unspecified	0.003	0.997	0.000
H61 Other disorders of external ear	0.003	0.997	0.000
Z01.0 Examination of eyes and vision	0.003	0.997	0.000
Z52.3 Bone marrow donor	0.000	0.997	0.003
K12.2 Cellulitis and abscess of mouth	0.000	0.997	0.003
O34.0 Maternal care for congenital malformation of uterus	0.003	0.997	0.000
Z01.1 Examination of ears and hearing	0.003	0.997	0.000
M62.81 Other specified disorders of muscle (Shoulder region)	0.003	0.997	0.000
O34.8 Maternal care for other abnormalities of pelvic organs	0.003	0.997	0.000
K06.8 Other specified disorders of gingiva and edentulous alveolar ridge	0.003	0.997	0.000
Z92.8 Personal history of other medical treatment	0.003	0.997	0.000
M62.89 Other specified disorders of muscle (Site unspecified)	0.003	0.997	0.000
N04.9 Unspecified	0.000	0.997	0.003
O34.6 Maternal care for abnormality of vagina	0.003	0.997	0.000
M62.8 Other specified disorders of muscle	0.003	0.997	0.000
Z45.1 Adjustment and management of infusion pump	0.000	0.997	0.003
I87.9 Disorder of vein, unspecified	0.000	0.997	0.003
O34.5 Maternal care for other abnormalities of gravid uterus	0.003	0.997	0.000
O34.4 Maternal care for other abnormalities of cervix	0.003	0.997	0.000
H61.8 Other specified disorders of external ear	0.003	0.997	0.000
O34.9 Maternal care for abnormality of pelvic organ, unspecified	0.003	0.997	0.000
M41.99 Scoliosis, unspecified (Site unspecified)	0.000	0.997	0.003
I87.0 Postphlebitic syndrome	0.000	0.997	0.003
S02.30 Fracture of orbital floor (closed)	0.000	0.997	0.003
O34.3 Maternal care for cervical incompetence	0.003	0.997	0.000
Y84 Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure	0.003	0.997	0.000
V09.9 Pedestrian injured in unspecified transport accident	0.003	0.997	0.000
Y84.0 Cardiac catheterisation	0.003	0.997	0.000
Y84.1 Kidney dialysis	0.003	0.997	0.000
V09 Pedestrian injured in other and unspecified transport accidents	0.002	0.998	0.000
M62.83 Other specified disorders of muscle (Forearm)	0.002	0.998	0.000
V09.0 Pedestrian injured in nontraffic accident involving other and unspecified motor vehicles	0.002	0.998	0.000
E34.0 Carcinoid syndrome	0.002	0.998	0.000
H83.0 Labyrinthitis	0.002	0.998	0.000
E34 Other endocrine disorders	0.002	0.998	0.000
M54.46 Lumbago with sciatica (Lumbar region)	0.000	0.998	0.002
M62.87 Other specified disorders of muscle (Ankle and foot)	0.002	0.998	0.000
H61.3 Acquired stenosis of external ear canal	0.002	0.998	0.000
K86.2 Cyst of pancreas	0.002	0.998	0.000
D89.2 Hypergammaglobulinaemia, unspecified	0.002	0.998	0.000
Z96.8 Presence of other specified functional implants	0.002	0.998	0.000
I87.1 Compression of vein	0.000	0.998	0.002
E34.8 Other specified endocrine disorders	0.002	0.998	0.000
H18.6 Keratoconus	0.002	0.998	0.000
Z01.2 Dental examination	0.002	0.998	0.000
B00.4 Herpesviral encephalitis	0.002	0.998	0.000
L89.9 Decubitus ulcer and pressure area, unspecified	0.002	0.998	0.000
O34.7 Maternal care for abnormality of vulva and perineum	0.002	0.998	0.000
B00.9 Herpesviral infection, unspecified	0.002	0.998	0.000
K51.2 Ulcerative (chronic) proctitis	0.002	0.998	0.000
V09.1 Pedestrian injured in unspecified nontraffic accident	0.002	0.998	0.000
M62.82 Other specified disorders of muscle (Upper arm)	0.002	0.998	0.000
C64-C68 Malignant neoplasms of urinary tract	0.002	0.998	0.000
B00.2 Herpesviral gingivostomatitis and pharyngotonsillitis	0.002	0.998	0.000
C54 Malignant neoplasm of corpus uteri	0.000	0.998	0.002
E34.9 Endocrine disorder, unspecified	0.002	0.998	0.000
E34.3 Short stature, not elsewhere classified	0.002	0.998	0.000
Y84.7 Blood-sampling	0.002	0.998	0.000
Y84.5 Insertion of gastric or duodenal sound	0.002	0.998	0.000
M62.84 Other specified disorders of muscle (Hand)	0.002	0.998	0.000
H53.8 Other visual disturbances	0.000	0.998	0.002
B00 Herpesviral [herpes simplex] infections	0.002	0.998	0.000
Y84.3 Shock therapy	0.002	0.998	0.000
B00.1 Herpesviral vesicular dermatitis	0.002	0.998	0.000
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone	0.002	0.998	0.000
R82.9 Other and unspecified abnormal finding in urine	0.000	0.998	0.002
M62.86 Other specified disorders of muscle (Lower leg)	0.002	0.998	0.000
M79.87 Other specified soft tissue disorders (Ankle and foot)	0.000	0.998	0.002
R68.0 Hypothermia, not associated with low environmental temperature	0.002	0.998	0.000
M25.85 Other specified joint disorders (Pelvic region and thigh)	0.002	0.998	0.000
H01.0 Blepharitis	0.002	0.998	0.000
O34.1 Maternal care for tumour of corpus uteri	0.002	0.998	0.000
Y84.9 Medical procedure, unspecified	0.002	0.998	0.000
V09.3 Pedestrian injured in unspecified traffic accident	0.002	0.998	0.000
V09.2 Pedestrian injured in traffic accident involving other and unspecified motor vehicles	0.002	0.998	0.000
B98 Other specified infectious agents as the cause of diseases classified to other chapters	0.000	0.998	0.002
C66 Malignant neoplasm of ureter	0.002	0.998	0.000
M71.26 Synovial cyst of popliteal space [Baker]-Lower Leg	0.000	0.998	0.002
E34.5 Androgen resistance syndrome	0.002	0.998	0.000
E34.4 Constitutional tall stature	0.002	0.998	0.000
E34.2 Ectopic hormone secretion, not elsewhere classified	0.002	0.998	0.000
E34.1 Other hypersecretion of intestinal hormones	0.002	0.998	0.000
M62.80 Other specified disorders of muscle (Multiple sites)	0.002	0.998	0.000
Z45 Adjustment and management of implanted device	0.000	0.998	0.002
C54.9 Corpus uteri, unspecified	0.000	0.998	0.002
V02.1 Traffic accident	0.002	0.998	0.000
W07.9 Unspecified place	0.002	0.998	0.000
Z72.2 Drug use	0.002	0.998	0.000
E22 Hyperfunction of pituitary gland	0.002	0.998	0.000
C68 Malignant neoplasm of other and unspecified urinary organs	0.002	0.998	0.000
L89.2 Stage III decubitus ulcer	0.002	0.998	0.000
M41.90 Scoliosis, unspecified (Multiple sites in spine)	0.000	0.998	0.002
E14.3 With ophthalmic complications	0.002	0.998	0.000
M62.88 Other specified disorders of muscle (Other)	0.002	0.998	0.000
E26.0 Primary hyperaldosteronism	0.002	0.998	0.000
E26 Hyperaldosteronism	0.002	0.998	0.000
C81.1 Nodular sclerosis	0.000	0.998	0.002
B02 Zoster [herpes zoster]	0.002	0.998	0.000
J70.1 Chronic and other pulmonary manifestations due to radiation	0.002	0.998	0.000
Z01.8 Other specified special examinations	0.002	0.998	0.000
M41.86 Other forms of scoliosis (Lumbar region)	0.000	0.998	0.002
C54.8 Overlapping lesion of corpus uteri	0.000	0.998	0.002
C54.3 Fundus uteri	0.000	0.998	0.002
C54.2 Myometrium	0.000	0.998	0.002
C54.0 Isthmus uteri	0.000	0.998	0.002
E26.9 Hyperaldosteronism, unspecified	0.002	0.998	0.000
M18.9 Arthrosis of first carpometacarpal joint, unspecified	0.000	0.998	0.002
B00.7 Disseminated herpesviral disease	0.002	0.998	0.000
B00.3 Herpesviral meningitis	0.002	0.998	0.000
B00.0 Eczema herpeticum	0.002	0.998	0.000
V02 Pedestrian injured in collision with two- or three-wheeled motor vehicle	0.002	0.998	0.000
H18.8 Other specified disorders of cornea	0.002	0.998	0.000
B00.8 Other forms of herpesviral infection	0.002	0.998	0.000
H72.8 Other perforations of tympanic membrane	0.002	0.998	0.000
C65 Malignant neoplasm of renal pelvis	0.002	0.998	0.000
W19.1 Residential institution	0.000	0.998	0.002
Z45.3 Adjustment and management of implanted hearing device	0.000	0.998	0.002
C68.9 Urinary organ, unspecified	0.002	0.998	0.000
F32.1 Moderate depressive episode	0.002	0.998	0.000
G80.9 Infantile cerebral palsy, unspecified	0.002	0.998	0.000
V01.1 Traffic accident	0.002	0.998	0.000
B98.1 Vibrio vulnificus as the cause of diseases classified to other chapters	0.000	0.998	0.002
M41.9 Scoliosis, unspecified	0.000	0.998	0.002
V01 Pedestrian injured in collision with pedal cycle	0.002	0.998	0.000
V01-V09 Pedestrian injured in transport accident	0.002	0.998	0.000
M62.96 Disorder of muscle, unspecified (Lower leg)	0.002	0.998	0.000
C81.9 Hodgkin's disease, unspecified	0.000	0.998	0.002
E22.1 Hyperprolactinaemia	0.002	0.998	0.000
H35 Other retinal disorders	0.002	0.998	0.000
J70 Respiratory conditions due to other external agents	0.002	0.998	0.000
E20-E35 Disorders of other endocrine glands	0.002	0.998	0.000
H35.9 Retinal disorder, unspecified	0.002	0.998	0.000
M62.9 Disorder of muscle, unspecified	0.002	0.998	0.000
E22.9 Hyperfunction of pituitary gland, unspecified	0.002	0.998	0.000
E22.8 Other hyperfunction of pituitary gland	0.002	0.998	0.000
M62.6 Muscle strain	0.002	0.998	0.000
M62.66 Muscle strain (Lower leg)	0.002	0.998	0.000
C68.8 Overlapping lesion of urinary organs	0.001	0.998	0.000
C68.1 Paraurethral glands	0.001	0.998	0.000
M62 Other disorders of muscle	0.002	0.998	0.000
E22.0 Acromegaly and pituitary gigantism	0.002	0.998	0.000
R52.1 Chronic intractable pain	0.000	0.998	0.002
C68.0 Urethra	0.001	0.998	0.000
E26.8 Other hyperaldosteronism	0.001	0.998	0.000
E26.1 Secondary hyperaldosteronism	0.001	0.998	0.000
E27.9 Disorder of adrenal gland, unspecified	0.002	0.998	0.000
G37.9 Demyelinating disease of central nervous system, unspecified	0.000	0.998	0.002
Y84.4 Aspiration of fluid	0.001	0.998	0.001
B02.7 Disseminated zoster	0.001	0.998	0.000
B02.1 Zoster meningitis	0.001	0.998	0.000
B02.0 Zoster encephalitis	0.001	0.998	0.000
J70.0 Acute pulmonary manifestations due to radiation	0.002	0.998	0.000
A08.4 Viral intestinal infection, unspecified	0.000	0.998	0.002
K44.9 Diaphragmatic hernia without obstruction or gangrene	0.000	0.998	0.002
R45.2 Unhappiness	0.000	0.998	0.002
Z45.9 Adjustment and management of unspecified implanted device	0.000	0.998	0.001
G97.1 Other reaction to spinal and lumbar puncture	0.000	0.998	0.002
N88.9 Noninflammatory disorder of cervix uteri, unspecified	0.000	0.998	0.002
V02.9 Unspecified whether traffic or nontraffic accident	0.001	0.998	0.000
V02.0 Nontraffic accident	0.001	0.998	0.000
Z01.4 Gynaecological examination (general)(routine)	0.001	0.998	0.000
E28 Ovarian dysfunction	0.002	0.998	0.000
O86.0 Infection of obstetric surgical wound	0.002	0.998	0.000
V01.0 Nontraffic accident	0.001	0.998	0.000
D89.0 Polyclonal hypergammaglobulinaemia	0.002	0.998	0.000
J70.4 Drug-induced interstitial lung disorder, unspecified	0.001	0.998	0.000
K66.8 Other specified disorders of peritoneum	0.002	0.998	0.000
E31 Polyglandular dysfunction	0.001	0.998	0.000
M48.07 Spinal stenosis (Lumbosacral region)	0.000	0.998	0.002
B02.8 Zoster with other complications	0.001	0.998	0.000
Z52 Donors of organs and tissues	0.000	0.998	0.002
M19.17 Post-traumatic arthrosis of other joints (Ankle and foot)	0.002	0.998	0.000
M87.85 Other osteonecrosis (Pelvic region and thigh)	0.001	0.998	0.000
R82 Other abnormal findings in urine	0.000	0.998	0.002
M25.86 Other specified joint disorders (Lower leg)	0.002	0.998	0.000
M25.81 Other specified joint disorders (Shoulder region)	0.001	0.998	0.000
M41.98 Scoliosis, unspecified (Sacral and sacrococcygeal region)	0.000	0.998	0.001
M41.93 Scoliosis, unspecified (Cervicothoracic region)	0.000	0.998	0.001
M41.91 Scoliosis, unspecified (Occipito-atlanto-axial region)	0.000	0.998	0.001
M62.65 Muscle strain (Pelvic region and thigh)	0.001	0.998	0.000
M65.94 Synovitis and tenosynovitis, unspecified (Hand)	0.000	0.998	0.002
J98.1 Pulmonary collapse	0.000	0.998	0.002
M17.5 Other secondary gonarthrosis	0.002	0.998	0.000
M41.8 Other forms of scoliosis	0.000	0.998	0.001
O86.1 Other infection of genital tract following delivery	0.001	0.998	0.000
V06 Pedestrian injured in collision with other nonmotor vehicle	0.001	0.998	0.000
V05 Pedestrian injured in collision with railway train or railway vehicle	0.001	0.998	0.000
V03 Pedestrian injured in collision with car, pick-up truck or van	0.001	0.998	0.000
M62.68 Muscle strain (Other)	0.001	0.998	0.000
M62.99 Disorder of muscle, unspecified (Site unspecified)	0.001	0.998	0.000
B00.5 Herpesviral ocular disease	0.001	0.998	0.000
E21.0 Primary hyperparathyroidism	0.002	0.998	0.000
E28.3 Primary ovarian failure	0.001	0.998	0.000
H35.1 Retinopathy of prematurity	0.001	0.998	0.000
J70.9 Respiratory conditions due to unspecified external agent	0.001	0.998	0.000
J70.8 Respiratory conditions due to other specified external agents	0.001	0.998	0.000
J70.3 Chronic drug-induced interstitial lung disorders	0.001	0.998	0.000
J70.2 Acute drug-induced interstitial lung disorders	0.001	0.998	0.000
M25.8 Other specified joint disorders	0.002	0.998	0.000
R45.8 Other symptoms and signs involving emotional state	0.001	0.998	0.000
D89 Other disorders involving the immune mechanism, not elsewhere classified	0.002	0.998	0.000
E35 Disorders of endocrine glands in diseases classified elsewhere	0.001	0.998	0.000
E32 Diseases of thymus	0.001	0.998	0.000
E30 Disorders of puberty, not elsewhere classified	0.001	0.998	0.000
K86 Other diseases of pancreas	0.002	0.998	0.000
M62.69 Muscle strain (Site unspecified)	0.001	0.998	0.000
M62.67 Muscle strain (Ankle and foot)	0.001	0.998	0.000
M62.64 Muscle strain (Hand)	0.001	0.998	0.000
M62.63 Muscle strain (Forearm)	0.001	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations